Xiaofang Guo Selected Research

Xiaofang Guo Research Topics

Disease

18	Neoplasms (Cancer) 06/2020 - 05/2011
7	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2012
7	Nasopharyngeal Carcinoma 01/2017 - 01/2012
5	Infections 01/2022 - 01/2012
4	Carcinogenesis 06/2020 - 09/2011
3	Hypoxia (Hypoxemia) 06/2020 - 01/2019
3	Adenocarcinoma of Lung 06/2020 - 08/2016
3	Breast Neoplasms (Breast Cancer) 01/2018 - 01/2017
2	Malaria 06/2022 - 05/2014
2	Hodgkin Disease (Hodgkin's Disease) 06/2018 - 07/2016
2	Triple Negative Breast Neoplasms 12/2017 - 01/2017
2	Lupus Nephritis 01/2014 - 02/2013
2	Glioma (Gliomas) 12/2011 - 05/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022
1	Pregnancy Complications 01/2022
1	Cytokine Release Syndrome 01/2022
1	COVID-19 01/2022
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Lung Injury 01/2021
1	Endometriosis 01/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 06/2020
1	Hypoalbuminemia 06/2020
1	Premature Birth (Birth, Premature) 01/2020
1	Rupture 01/2020
1	Preterm Premature Rupture of the Membranes 01/2020
1	Pneumothorax 07/2019
1	Hyperlipidemias (Hyperlipidemia) 12/2018
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2011
6	MicroRNAs (MicroRNA)IBA 01/2017 - 05/2011
5	Messenger RNA (mRNA)IBA 01/2022 - 01/2013
3	EnzymesIBA 01/2021 - 01/2012
3	BerberineIBA 12/2018 - 03/2013
2	Small Interfering RNA (siRNA)IBA 01/2022 - 06/2020
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 01/2012
2	CollagenIBA 01/2021 - 05/2020
2	Sorafenib (BAY 43-9006)FDA Link 06/2020 - 12/2017
2	CateninsIBA 06/2020 - 12/2017
2	Cadherins (E-Cadherin)IBA 06/2020 - 12/2017
2	VimentinIBA 06/2020 - 12/2017
2	Pharmaceutical PreparationsIBA 05/2020 - 12/2017
2	B7-H1 AntigenIBA 06/2018 - 01/2017
2	Nucleosomes (Nucleosome)IBA 01/2014 - 02/2013
2	AutoantibodiesIBA 01/2014 - 02/2013
2	Histones (Histone)IBA 01/2014 - 02/2013
2	Biomarkers (Surrogate Marker)IBA 01/2013 - 05/2011
2	LactoferrinIBA 12/2012 - 01/2012
1	InsecticidesIBA 06/2022
1	Ribosomal DNA (rDNA)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Viral RNAIBA 01/2022
1	ChemokinesIBA 01/2022
1	SteroidsIBA 01/2022
1	Interleukin-11 (Interleukin 11)IBA 01/2022
1	4-hydroxyestradiolIBA 01/2021
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2021
1	p38 Mitogen-Activated Protein KinasesIBA 01/2021
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2021
1	SmokeIBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	2-hydroxyestradiolIBA 01/2021
1	Propranolol (Inderal)FDA LinkGeneric 01/2021
1	tizoxanideIBA 12/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2020
1	CarbonIBA 06/2020
1	Glutamine (L-Glutamine)FDA Link 06/2020
1	AlbuminsIBA 06/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 06/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2020
1	Capsules (Microcapsules)IBA 05/2020
1	ApoferritinsIBA 05/2020
1	AcidsIBA 05/2020
1	Peptide Hydrolases (Proteases)FDA Link 05/2020
1	Collagenases (Collagenase)FDA Link 05/2020
1	NanocapsulesIBA 05/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Thrombin FDA Link 01/2020
1	Thromboplastin (Tissue Factor)IBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	LipidsIBA 12/2018
1	LDL Receptors (LDL Receptor)IBA 12/2018
1	ResveratrolIBA 12/2018
1	LigandsIBA 06/2018

Therapy/Procedure

7	Therapeutics 01/2019 - 05/2011
3	Drug Therapy (Chemotherapy) 05/2020 - 10/2012
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 01/2017
2	Radiotherapy 07/2016 - 10/2012
1	Critical Care (Surgical Intensive Care) 06/2020
1	Microspheres (Microsphere) 01/2020
1	Chest Tubes (Chest Tube) 07/2019
1	Punctures 07/2019
1	Precision Medicine 05/2018